Investment Opportunities in the Biosimulation Market
The global Biosimulation Market size is predicted to reach USD 10.58 billion with a CAGR of 18.7% till 2030.
Demand for biosimulation is increasing, owing to availability of biosimulation software such as Phoenix platform, which is recognized as the premier software to review new drug and biologics license applications across the globe. It is used by 6,000 scientists at biopharmaceutical companies, academic and non-profit institutions, and regulatory agencies.
The global Biosimulation Market size is predicted to reach USD 10.58 billion with a CAGR of 18.7% till 2030.
Demand for biosimulation is increasing, owing to availability of biosimulation software such as Phoenix platform, which is recognized as the premier software to review new drug and biologics license applications across the globe. It is used by 6,000 scientists at biopharmaceutical companies, academic and non-profit institutions, and regulatory agencies.
Investment Opportunities in the Biosimulation Market
The global Biosimulation Market size is predicted to reach USD 10.58 billion with a CAGR of 18.7% till 2030.
Demand for biosimulation is increasing, owing to availability of biosimulation software such as Phoenix platform, which is recognized as the premier software to review new drug and biologics license applications across the globe. It is used by 6,000 scientists at biopharmaceutical companies, academic and non-profit institutions, and regulatory agencies.
0 Kommentare
0 Geteilt
86 Ansichten
0 Bewertungen
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian